Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2023-08-08 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Lupin Receives Approval from U.S. FDA for Fluocinolone Acetonide Body Oil.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of U.S. FDA approval for a pharmaceutical product by Lupin Limited. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI Listing Regulations, which governs material event disclosures. The content is a corporate announcement about a regulatory approval event, not a financial report, earnings release, or management discussion. The document length is 4119 characters, relatively short, and it is clearly a disclosure announcement rather than a detailed report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-08-08 English
Lupin Digital Health Launches first-of-its-kind Digital Heart Failure Clinic in India.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new digital health product by Lupin Digital Health. It is addressed to stock exchanges as a disclosure pursuant to a listing regulation, indicating it is a regulatory announcement. The content focuses on product launch and company information rather than financial results, management changes, or detailed financial data. The document length is about 7,310 characters, which is relatively short and typical for a press release. There is no indication of financial statements, audit information, voting results, or other report types. Therefore, this document fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for disclosures that do not fit other specific categories.
2023-08-07 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated August 7, 2023, announcing the launch of a new digital health product by Lupin Digital Health. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI Listing Regulations, which typically covers material events or information about the company. The content focuses on product launch and business update rather than financial results, management changes, or regulatory filings. It does not contain financial statements or detailed financial analysis, nor does it announce voting results, dividends, or capital changes. The document is a corporate announcement of a business development event, fitting the category of a Regulatory Filing (RNS) as a general regulatory announcement and disclosure under listing obligations. The document length (7300 characters) and content confirm it is not a report publication announcement or a full report. Therefore, the best classification is Regulatory Filings (RNS).
2023-08-07 English
Audio recording of the Earnings Call - Q1 FY24.
Call Transcript Classification · 80% confidence The document is a letter addressed to stock exchanges informing them about the hosting of the audio recording of the Earnings Call for Q1 FY24 on the company's website. It references the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating a regulatory compliance announcement. The document does not contain the transcript or detailed financial data itself, but rather provides a link to the audio recording. The document length is short (1644 characters), and it is an announcement about the availability of the earnings call recording, not the call transcript itself. Therefore, it should be classified as a Call Transcript (CT) because it relates directly to the earnings call content, but since it only announces the audio recording and does not contain the transcript text, the best fit is Call Transcript (CT) with moderate confidence, as the actual transcript is not included but the document is about the earnings call content.
2023-08-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the hosting of the audio recording of the Earnings Call for Q1 FY24 on the company's website. It references the SEBI regulations for disclosure but does not contain any financial data or detailed earnings information itself. The document is short (1646 characters) and serves as an announcement of the availability of the earnings call recording rather than the transcript or report itself. Therefore, it fits best under the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than a Call Transcript (CT) or Earnings Release (ER).
2023-08-04 English
Shareholders meeting
Regulatory Filings
2023-08-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.